Decisions about add-on reimbursement for medical devices in France in November 2019

16

Dec 2019

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in November 2019.

Five (5) decision was released regarding orthopedic devices:

  • UNLOADER ONE SMARTDOSING, articulated knee relief orthosis (application for registration, rejected due to the absence of specific clinical data)
  • NARVAL ORM, custom mandibular advancement orthosis  (application to change the registration conditions + renewal; approved)
  • JUGGERSTITCH, arthroscopic meniscal repair system (application for registration, approved)
  • EXABONE PUTTY, absorbable synthetic bone substitute (application for registration, approved)
  • EXABONE PASTE, absorbable synthetic bone substitute (application for registration, approved)

Seven (7) decisions were released for cardiovascular devices:

  • MITRACLIP NTR, mitral repair clip edge to edge (application to change the registration conditions; approved)
  • MITRACLIP XTR, mitral repair clip edge to edge (application to change the registration conditions; approved)
  • ISTENT INJECT W, micro-stent trabecular bypass (application for registration, approved)
  • Ellipsys, vascular access system for percutaneous creation of an arteriovenous anastomosis by thermofusion (application for registration, rejected because the provided data do not establish the interest)
  • PROMUS PREMIER BTK (PROMUS PREMIER OVER THE WIRE BTK and PROMUS PREMIER MONORAIL BTK), peripheral stent with release of active ingredient (everolimus) (renewal of registration, approved)
  • WALLSTENT-UNI, self-expanding bare stent (renewal of registration, approved)
  • TALEO, class III energy restoring foot (application for registration, approved)

Six (6) decisions were released for other devices:

  • FREESTYLE COMFORT, portable mobile oxygen concentrator (application for registration, approved)
  • NEOCATE, food for special medical purposes (renewal of registration, approved)
  • INTERSTIM II, neuromodulator of the sacred roots (renewal of registration, approved)
  • CARPO 2 SE, modular electric scooter (application for registration, approved)
  • INNOSPIRE GO, vibrating screen nebulization system (application for registration, approved)
  • AEROLIGHT with EXTRANEB + nebulizer, pneumatic nebulization system (application for registration, approved)

See the list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more